Glycopyrrolate Injection, Solution
Product Images NDC 65219-801

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 65219-801). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Gly0g 0000 01)

FDA Label Image

Logo (Gly0g 0000 02)

FDA Label Image

Package Label – Principal Display – Glycopyrrolate Injection, Usp 0.2 mg Per mL Vial Label (Gly0g 0000 03)

Package Label – Principal Display – Glycopyrrolate Injection, Usp 0.2 mg Per mL Vial Label (Gly0g 0000 03)
This text provides information about a medication called Glycopyrrolate. It is available as an injection and contains 0.2 mg of the active ingredient per mL. The medication is indicated for intramuscular or intravenous use. The product is manufactured by Fresenius Kabi and is supplied in a single-dose vial containing 1 mL. It is important to note that the medication contains benzyl alcohol. The NDC number for this product is 65219-801-00, and there is a lot number/expiration date provided as well (LOT/EXP). This text does not contain any non-English characters and can be used to evaluate the medication.*
FDA Label Image

Package Label – Principal Display – Glycopyrrolate Injection, Usp 0.2 mg Per mL Tray Label (Gly0g 0000 04)

Package Label – Principal Display – Glycopyrrolate Injection, Usp 0.2 mg Per mL Tray Label (Gly0g 0000 04)
This is a description of an injection medication with the NDC number 65219-801-01 and RFID technology for tracking. The medication is a solution of 0.2 mg per mL and is not suitable for use in newborns. It can be administered intramuscularly or intravenously. The medication contains benzyl alcohol as a preservative and is available in single-dose vials of 1mL each. The usual dosage should be referred to in the package insert. The medication should be stored at a temperature of 20° to 25°C (68° to 77°F). The manufacturer of the medication is Fresenius Kabi located in Lake Zurich, IL. For more information, you can visit their website at www.fresenius-kabi.com/us.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.